Clinical Trials Logo

Clinical Trial Summary

Ventricular tachycardia (VT) is a leading cause of death and suffering in the Veteran population. Currently, ablation procedures are performed to destroy the diseased tissue that causes this problem. This study will test to see if a new non-invasive targeting tool can help guide doctors during the procedure and improve the outcomes of the ablation procedure. Once this study is completed, the investigators will know whether this tool could help increase the efficacy, safety and accuracy of ablation therapy of fatal heart rhythms.


Clinical Trial Description

Ventricular tachycardia (VT) remains a leading cause of death and morbidity in the Veteran population, but current ablation procedures to treat VT are limited by high VT recurrence rates up to 60%, lengthy invasive procedures, and invasive risks and difficulty in accurately localizing all the critical arrhythmogenic sites sustaining VT. The long-term goal is to harness the power of computational modeling to improve the efficacy, efficiency and safety of VT catheter ablation. The overall objective of this study is to perform a randomized clinical trial to see if the incorporation of computational ECG mapping guidance during VT ablation improves clinical outcomes of VT recurrence and ablation efficiency. The central hypothesis is that use of forward solution computational ECG mapping can improve clinical outcomes of VT ablation by localizing VT origins located in arrhythmogenic myocardial substrate that are critical in sustaining VT. The rationale is that novel non-invasive ECG mapping may be able to overcome the challenges of conventional invasive mapping techniques and improve the low success rates of VT ablation. The central hypothesis will be tested by pursuing one primary specific aim: Perform a randomized clinical trial to determine whether the use of computational ECG analysis during VT ablation can 1) reduce recurrent VT and 2) decrease intra-procedural mapping time, fluoroscopy time, and number of invasive access sites. This randomized clinical trial will test whether a VT ablation strategy incorporating computational mapping will improve efficiency and freedom from VT compared to standard-of-care ablation. The research proposed is innovative because it tests the ability of a novel computational analysis technique developed by the investigators' lab to guide ablation of critical arrhythmogenic tissue underlying VT. The proposed research is significant because it is expected to translate novel computational techniques and rigorously test its ability to improve the efficacy and efficiency of a complex ablation procedure to treat a fatal heart rhythm disorder. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06464315
Study type Interventional
Source VA Office of Research and Development
Contact Gordon Ho, MD
Phone (858) 642-3147
Email Gordon.Ho@va.gov
Status Not yet recruiting
Phase N/A
Start date October 1, 2024
Completion date September 30, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT03453645 - Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
Completed NCT05791032 - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study N/A
Completed NCT05970120 - A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter N/A
Completed NCT04011631 - Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. N/A
Recruiting NCT03536052 - Ablation at Virtual-hEart pRedicted Targets for VT N/A
Not yet recruiting NCT06063811 - Ventricular Tachycardia Ablation in LVAD Patients
Enrolling by invitation NCT02962076 - Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia Early Phase 1
Not yet recruiting NCT02784912 - Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation N/A
Completed NCT01791543 - Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia N/A
Terminated NCT02891863 - Low Energy Therapy to Convert Ventricular Tachycardias Phase 0
Terminated NCT01546207 - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia N/A
Completed NCT01294267 - Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation N/A
Terminated NCT00383799 - Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia Phase 4
Completed NCT04884100 - enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening N/A
Completed NCT04642963 - Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia N/A
Recruiting NCT05377216 - Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation Early Phase 1
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Recruiting NCT03631303 - Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
Recruiting NCT03611465 - Creation of a Pace-mapping Atlas on Healthy and Pathological Hearts N/A